MFN2 and Parkinson disease: Ubiquitination of MFN-1 and MFN-2 is reduced in either cell lines with Parkin deficiency or fibroblasts derived from PD patients harboring Parkin mutations (Gegg et al., 2010; Rakovic et al., 2011).